Hypertensive heart disease vs. Transthyretin cardiac amyloidosis: what are the differential features in real life?

Back

HFA Premium Access

Hypertensive heart disease vs. Transthyretin cardiac amyloidosis: what are the differential features in real life?

Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension

Topic: Hypertension, Other

Speaker: Doctor C. Goena Vives (Donostia, ES)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)

3 presentations

0 follower

6 more presentations in this session

Serum proteome profiling reflects the risk of pulmonary hypertension in chronic heart failure patients

Speaker: Mr J. Morze (Gothenburg, SE)

Association of right ventricular deformation parameters and pulmonary hypertension markers in patients with asymptomatic primary mitral regurgitation and preserved left ventricular ejection fraction

Speaker: Ms R. Dirsiene (Kaunas, LT)

Artificial intelligence for prediction of pulmonary arterial hypertension detection using computer tomography

Speaker: Doctor T. Kivrak (Elazig, TR)

Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina

Speaker: Doctor J. Soricetti (Buenos Aires, AR)

Association between right ventricle size and function on outcomes in COVID-19

Speaker: Doctor N. Bodagh (London, GB)

Access the full session

Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension

Speakers: Doctor C. Goena Vives, Mr J. Morze, Ms R. Dirsiene, Doctor T. Kivrak, Doctor J. Soricetti...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources